Marcie A. Goldstein
Lawyers
Filters
Open Lending $305.9 million secondary offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $305.9 million secondary offering of 10,925,000 shares of common stock…
HumanCo Acquisition $287.5 million IPO
Davis Polk advised the underwriter in connection with the initial public offering of 28,750,000 units of HumanCo Acquisition Corp., including 3,750,000 units purchased pursuant to the…
Nebula Caravel Acquisition $275 million IPO
Davis Polk advised the representatives of the several underwriters, in connection with the initial public offering of 27,500,000 units of Nebula Caravel Acquisition Corp., including 2…
Array Technologies $1.2 billion secondary offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $1.2 billion SEC-registered secondary offering of 36,656,250 shares of…
Far Peak Acquisition $550 million IPO
Davis Polk advised the sole underwriter in connection with the $550 million initial public offering of 55,000,000 units of Far Peak Acquisition Corporation. Each unit consists of one…
Oak Street Health $297.9 million secondary offering
Davis Polk advised the joint book-running managers in connection with the $297.9 million secondary offering of 6,477,293 shares of common stock of Oak Street Health, Inc. by certain…
Capital Investment Corp. V $345 million IPO
Davis Polk advised the underwriters in connection with the initial public offering of 34,500,000 units of Capitol Investment Corp. V for aggregate proceeds of $345 million, which…
Maravai LifeSciences Holdings $1.863 billion IPO
Davis Polk advised the representatives of the several underwriters in connection with the initial public offering of 69,000,000 shares of Class A common stock of Maravai LifeSciences…
Stoke Therapeutics $112 million follow-on offering
Davis Polk advised the representatives of the underwriters in connection with the $112 million public offering of 2,500,000 shares of common stock of Stoke Therapeutics, Inc., which…
Consonance-HFW Acquisition $80 million IPO
Davis Polk advised the sole book-running manager in connection with the $80 million initial public offering of 8,000,000 units of Consonance-HFW Acquisition Corp. Each unit consists of…